Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents
Clinical trial NCT00645411 · COMPLETED
Trial details
- NCT number
- NCT00645411
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-02-01
- Enrollment
- 3604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.